Home
Mesoblast Ltd
Mesoblast to Evaluate Remestemcel-L in COVID-19 Lung Disease
Business
Mar 10 2020
5 min read

Mesoblast to Evaluate Remestemcel-L in COVID-19 Lung Disease

news images

Mesoblast Ltd has released a press release.

View Attachment